This price target is based on 0 analysts offering 12 month price targets for Georgia Healthcare Group PLC (GHG.L) in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.
The current consensus among 0 polled investment analysts is to n/a stock in Georgia Healthcare Group PLC (GHG.L). This rating has held steady since January 2021, when it changed from a Hold consensus rating.
Georgia Healthcare Group PLC, together with its subsidiaries, provides healthcare services in Georgia. It operates through Healthcare Services, Pharma, and Medical Insurance segments. As of December 31, 2017, the company operated 16 referral and specialty hospitals comprising 2,519 beds that offer secondary and tertiary level healthcare services; 21 community hospitals, including 495 beds providing basic outpatient and inpatient healthcare services; and 255 pharmacies under the GPC and Pharmadepot brand names. It also operates 16 district polyclinics, 24 express outpatient clinics, and dental clinics that offer outpatient diagnostic and treatment services; provides a range of medical insurance products, such as personal accident, term life, and medical and travel insurance policies to corporate and retail clients; and medicines, as well as Para pharmacy products. The company is headquartered in London, the United Kingdom. Georgia Healthcare Group PLC operates as a subsidiary of Georgia Capital PLC.